1-deoxynojirimycin has been researched along with B16 Melanoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, ML; Wang, RJ; Yang, CH | 1 |
| Guerrera, M; Ladisch, S | 1 |
| Fukuyasu, H; Inouye, S; Ishii, M; Shibahara, S; Tsuruoka, T; Usui, T | 1 |
| Anasagasti, MJ; Fuentes, AM; Mendoza, L; Olaso, E; Vidal-Vanaclocha, F | 1 |
| Branza-Nichita, N; Costin, GE; Dwek, RA; Negroiu, G; Petrescu, AJ; Petrescu, SM; Titu, H | 1 |
| Parsons, PG; Takahashi, H | 1 |
| Hori, Y; Imokawa, G; Kubota, Y; Shimada, S; Tsukamoto, K; Uno, A | 1 |
7 other study(ies) available for 1-deoxynojirimycin and B16 Melanoma
| Article | Year |
|---|---|
1-Deoxynojirimycin inhibits metastasis of B16F10 melanoma cells by attenuating the activity and expression of matrix metalloproteinases-2 and -9 and altering cell surface glycosylation.
Topics: 1-Deoxynojirimycin; Animals; Base Sequence; Cell Membrane; DNA Primers; Glycosylation; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Melanoma, Experimental; Mice; Neoplasm Metastasis; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinases | 2010 |
N-butyldeoxynojirimycin inhibits murine melanoma cell ganglioside metabolism and delays tumor onset.
Topics: 1-Deoxynojirimycin; Animals; Cell Division; Cell Line, Tumor; Ceramides; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gangliosides; Glucosyltransferases; Melanoma, Experimental; Mice; Neoplasm Transplantation | 2003 |
Inhibition of mouse tumor metastasis with nojirimycin-related compounds.
Topics: 1-Deoxynojirimycin; Animals; Antibiotics, Antineoplastic; Glucosamine; Glucuronidase; Glycoside Hydrolases; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Tumor Cells, Cultured | 1996 |
Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver.
Topics: 1-Deoxynojirimycin; Animals; Cell Adhesion; Cell Communication; Culture Media, Conditioned; Endothelium; Interleukin-1; Lectins, C-Type; Linear Models; Liver Neoplasms; Male; Mannose Receptor; Mannose-Binding Lectins; Melanoma, Experimental; Mice; Neoplasm Transplantation; Oligosaccharides; Receptors, Cell Surface | 1998 |
Investigation of the intracellular transport of tyrosinase and tyrosinase related protein (TRP)-1. The effect of endoplasmic reticulum (ER)-glucosidases inhibition.
Topics: 1-Deoxynojirimycin; Animals; Biological Transport, Active; Endoplasmic Reticulum; Glucosidases; Glycosylation; Intracellular Fluid; Melanoma, Experimental; Melanosomes; Membrane Glycoproteins; Mice; Microscopy, Electron; Monophenol Monooxygenase; Neoplasm Proteins; Oxidation-Reduction; Oxidoreductases; Protein Conformation; Protein Processing, Post-Translational; Proteins; Tumor Cells, Cultured | 1999 |
Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells.
Topics: 1-Deoxynojirimycin; Antibodies, Monoclonal; Antigens; Blotting, Western; Cell Survival; Chromatography, Affinity; Flow Cytometry; Glucosamine; Glucosidases; Humans; Indolizines; Melanocytes; Melanoma, Experimental; Methionine; Monophenol Monooxygenase; Skin Neoplasms; Subcellular Fractions; Sulfur Radioisotopes; Tumor Cells, Cultured | 1992 |
Role of asparagine-linked carbohydrates in pulmonary metastasis of B16-F10 murine melanoma cells: implication through glycosylation inhibition by nojirimycin.
Topics: 1-Deoxynojirimycin; Animals; Glucosamine; Glycosylation; Killer Cells, Natural; Lectins; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligosaccharides | 1992 |